2A0A image
Deposition Date 2005-06-16
Release Date 2006-04-11
Last Version Date 2024-05-01
Entry Detail
PDB ID:
2A0A
Keywords:
Title:
Solution Structure of Der f 13, Group 13 Allergen from House Dust Mites
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Calculated:
10
Conformers Submitted:
10
Selection Criteria:
back calculated data agree with experimental NOESY spectrum
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Der f 13
Gene (Uniprot):FABP5_3
Chain IDs:A
Chain Length:131
Number of Molecules:1
Biological Source:Dermatophagoides farinae
Ligand Molecules
Primary Citation
Nuclear magnetic resonance structure-based epitope mapping and modulation of dust mite group 13 allergen as a hypoallergen.
J Immunol. 176 4852 4860 (2006)
PMID: 16585580 DOI: 10.4049/jimmunol.176.8.4852

Abstact

IgE-mediated allergic response involves cross-linking of IgE bound on mast cells by specific surface epitopes of allergens. Structural studies on IgE epitopes of allergens are essential in understanding the characteristics of an allergen and for development of specific allergen immunotherapy. We have determined the structure of a group 13 dust mite allergen from Dermatophagoides farinae, Der f 13, using nuclear magnetic resonance. Sequence comparison of Der f 13 with homologous human fatty acid-binding proteins revealed unique surface charged residues on Der f 13 that may be involved in IgE binding and allergenicity. Site-directed mutagenesis and IgE binding assays have confirmed four surface charged residues on opposite sides of the protein that are involved in IgE binding. A triple mutant of Der f 13 (E41A_K63A_K91A) has been generated and found to have significantly reduced IgE binding and histamine release in skin prick tests on patients allergenic to group 13 dust mite allergens. The triple mutant is also able to induce PBMC proliferation in allergic patients with indices similar to those of wild-type Der f 13 and shift the secretion of cytokines from a Th2 to a Th1 pattern. Mouse IgG serum raised using the triple mutant is capable to block the binding of IgE from allergic patients to wild-type Der f 13, indicating potential for the triple mutant as a hypoallergen for specific immunotherapy. Findings in this study imply the importance of surface charged residues on IgE binding and allergenicity of an allergen, as was also demonstrated in other major allergens studied.

Legend

Protein

Chemical

Disease

Primary Citation of related structures